Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
43.45 USD | -2.38% |
|
+4.61% | -25.29% |
20/06 | Disc Medicine Insider Bought Shares Worth $3,000,024, According to a Recent SEC Filing | MT |
17/06 | BMO Capital Adjusts Price Target on Disc Medicine to $70 From $50, Maintains Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.29% | 1.32B | |
+24.17% | 52.73B | |
+37.49% | 39B | |
-9.34% | 38.52B | |
+29.46% | 30.38B | |
-12.26% | 26.39B | |
+11.31% | 26.08B | |
+44.97% | 14.15B | |
+32.45% | 12.6B | |
-5.72% | 11.51B |
- Stock Market
- Equities
- IRON Stock
- News Disc Medicine, Inc.
- BMO Capital Adjusts Price Target on Disc Medicine to $70 From $50, Maintains Outperform Rating